Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase I Study of Lenalidomide in Patients With Acute Leukemia

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01615042
First received: June 6, 2012
Last updated: January 19, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)